The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
 
Robert Connor Chick
No Relationships to Disclose
 
Mark B. Faries
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Delcath Systems; Novartis; Pulse Biosciences; Sanofi/Aventis
 
Diane F. Hale
No Relationships to Disclose
 
Phillip M. Kemp Bohan
No Relationships to Disclose
 
Annelies Hickerson
No Relationships to Disclose
 
Timothy J. Vreeland
No Relationships to Disclose
 
John William Myers
No Relationships to Disclose
 
Jessica L. Cindass
No Relationships to Disclose
 
Tommy A. Brown
No Relationships to Disclose
 
John Robert Hyngstrom
Honoraria - Castle Biosciences
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Castle Biosciences
 
James W. Jakub
No Relationships to Disclose
 
Jeffrey J. Sussman
No Relationships to Disclose
 
Adam C. Berger
Honoraria - Cardinal Health; Castle Biosciences
Consulting or Advisory Role - Castle Biosciences
Speakers' Bureau - Cardinal Health
Research Funding - Castle Biosciences
 
Montaser F. Shaheen
No Relationships to Disclose
 
G. Travis Clifton
No Relationships to Disclose
 
Thomas Wagner
Employment - Orbis Health Solutions
Leadership - Orbis Health Solutions
Stock and Other Ownership Interests - Orbis Health Solutions
Research Funding - Elios Pharmaceutical
Patents, Royalties, Other Intellectual Property - Orbis Health Solutions
Expert Testimony - Orbis Health Solutions
Travel, Accommodations, Expenses - Orbis Health Solutions
 
George Earl Peoples
Employment - Cancer Insight; Orbis Health Solutions
Leadership - Cancer Insight; Orbis Health Solutions
Stock and Other Ownership Interests - Cancer Insight; Orbis Health Solutions; Rapamycin Holdings
Consulting or Advisory Role - Abexxa Biologics; Heat Biologics; Pelican Therapeutics; Rapamycin Holdings
Research Funding - Genentech; Orbis Health Solutions; Sellas Life Sciences
Patents, Royalties, Other Intellectual Property - Royalties
Travel, Accommodations, Expenses - Cancer Insight; Heat Biologics; Orbis Health Solutions; Sellas Life Sciences